At the National Task Force on CME Provider/Industry Collaboration conference, held in October in Baltimore, CME professionals who work in the pharmaceutical industry were asked during a special session what emerging problems regarding...

An intensive, three-hour summit for senior-level pharmaceutical planners is one of the new features that will be offered at the Third Annual Pharmaceutical Meeting Planners Forum. Co-organized by Medical Meetings magazine and the Center for...

In the New Accreditation Council for CME accreditation system, which aims to position CME as “a strategic asset to the quality improvement and patient safety imperatives of the U.S. healthcare systems,” the CME mission will take on a pivotal role...

This Fall, a close friend of mine was diagnosed with breast cancer, underwent surgery, and began radiation treatments. While the physical aspects of dealing with such a serious illness are, obviously, a tremendous ordeal, my friend has also been...

At a breakout session on the granting process, held at the National Task Force on CME Provider/Industry Collaboration conference in Baltimore in October, three pharmaceutical company representatives provided insight on their companies' grants...

From Anne Taylor-Vaisey: This book by Richard Gunderman was just reviewed in the November 30 issue of the New England Journal of Medicine. I looked around and found some more reviews of the book: ...

According to the New York Times, the new head of Pfizer plans to lay off almost 2,400 of its sales force. Could this be good news for CME funding, or just an overall cutback now that they don't have quite as much to sell as they used to? The...

From Anne Taylor-Vaisey: A colleague just brought to my attention the June 2006 issue of Social Science and Medicine . This issue contains a special section on evidence-based medicine. Have a look at the abstracts and links for the section's nine...